Event
2022 Breast Cancer Highlights From International Medical Meetings: Third Annual Review
presented by Penn Medicine Abramson Cancer Center
1 other would like to attend.
Register Now
Thursday, September 22, 2022 5 PM
-
8:30 PM
America/New_York
Add to Calendar
Event info
LEARNING OBJECTIVES
At the completion of this course, participants should be able to:
- Identify clinical trial evidence that allows for the personalization of care in the management of early and advanced forms of breast cancer according to breast cancer phenotype
- Implement current and evolving roles for prognostic and predictive biomarkers to stratify risk and inform clinical decision making in the management of breast cancer
- List recent clinical trial results concerning the use of novel breast cancer treatment strategies
ACCREDITATION
|
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Penn Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. For more information please visit the official event page. |
1 other would like to attend.
Register Now